Red cell superoxide dismutase activity in sporadic amyotrophic lateral sclerosis

Journal of Clinical Neuroscience

Volumn 13, Issue 10, 2006, Pages 991-994

  Tuncel, Deniz ^a   Aydin, Nursel ^b   Aribal Kocatürk, Pelin ^b   Özelçi Kavas, Güzin ^b   Sarikaya, Sevda ^b  

^a KSU Medical School   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Amyotrophic lateral sclerosis; Diagnosis; Prognosis; Red cell superoxide dismutase

Indexed keywords

SUPEROXIDE DISMUTASE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; SPECTROPHOTOMETRY; STATISTICAL ANALYSIS;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; ERYTHROCYTES; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SPECTROPHOTOMETRY; SUPEROXIDE DISMUTASE;

EID: 33750987912     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2005.10.019     Document Type: Article

References (25)

1. Horton W.A., Eldridge R., and Brody J.A. Familial motor neuron disease: evidence for at least 3 different types. Neurology 26 (1976) 460-465
2. Haverkamp L.J., Appel V., and Appel S.H. Natural history of amyotrophic lateral sclerosis in a database population. Brain 118 (1995) 707-719
3. Andersen P.M. Genetic factors in the early diagnosis of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 1 Suppl.1 (2000) S31-S42
4. Cha C.I., Chung Y.H., Shin C., et al. Immunocytochemical study on the distribution of nitrotyrosine in the brain of the transgenic mice expressing a human Cu/Zn SOD mutation. Brain Res 853 (2000) 156-161
5. Siddique T., Nijhawan D., and Hentati A. Molecular genetic basis of familial ALS. Neurology 47 Suppl.2 (1996) S27-S35
6. Olsen M.K., Roberds S.L., Ellerbrock B.R., et al. Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord. Ann Neurol 50 (2001) 730-740
7. Deng H.-X., Hentati A., Tainer J.A., et al. Amyotrophic lateral sclerosis and structural defects in CuZn superoxide dismutase. Science 261 (1993) 1047-1051
8. Rosen D.R., Siddique T., Patteson D., et al. Mutations in CuZn-superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364 (1993) 59-62
9. Jones C.T., Swingler R.J., and Brock D.J.H. Identification of a novel SOD1 mutation in an apparently sporadic amyotrophic lateral sclerosis patient and the detection of Ile 113 Thr in three others. Hum Mol Genet 3 (1994) 649-650
10. Rainore L., Pinessi L., Tsuda T., et al. SOD1 missense mutation in an Italian family with ALS. Neurology 44 (1994) 347-349
11. Andersen P.M., Nilsson P., Keranen M.-L., et al. Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutation in Scandinavia. Brain 10 (1997) 1723-1737
12. Shaw C.E., Enayat Z.E., Chioza B.A., et al. Mutations in all five exons of SOD-1 may cause ALS. Ann Neurol 43 (1998) 390-394
13. Robberecht L., Van Den B., and Vleminckx V. Amyotrophic lateral sclerosis: pathogenesis. Acta Neurol Belg 100 (2000) 181-187
14. Shaw C.E., Enayat Z.E., Powel J.F., et al. Familial amyotrophic lateral sclerosis, molecular pathology of a patient with a SOD1 mutation. Neurology 49 (1997) 1612-1616
15. Andreassen O.A., Ferrante R.J., Klivenyi P., et al. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis. Ann Neurol 47 (2000) 447-455
16. Gurney M.E., Chin A.Y., Dal Canto M.C., et al. Motor neuron degeneration in mice that express a human CuZn-superoxide dismutase mutation. Science 264 (1994) 1772-1775
17. Andersen P.M., Forsgren L., Binzer M., et al. Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Brain 119 (1996) 1153-1172
18. Jacobsson J., Jonsson P.A., Andersen P.M., et al. Superoxide dismutase in CSF from amyotrophic lateral sclerosis patients with and without CuZn-superoxide dismutase mutations. Brain 124 (2001) 1461-1466
19. Kocatürk P.A., Tuncel D., Kavas G., et al. Red cell Cu/Zn-SOD and catalase activities are increased in ALS. Proceedings of the Second International Meeting on Free Radicals in Health and Disease: The Role of Oxidants and Antioxidants in the Regulation of Chronic Disease (2002), Istanbul, Turkey
20. Riviere M., Meininger V., Zeisser P., et al. An analysis of extended survival in patients with amyotrophic lateral sclerosis treated with riluzole. Arch Neurol 55 (1998) 526-528
21. Miller R.G., Munsat T.L., Swash M., et al. Consensus guidelines for the design and implementation of clinical trials in ALS. J Neurol Sci 169 (1999) 2-12
22. Winterbourn C.C., Hawkins R.E., Brian M., et al. Red cell superoxide dismutase activity. J Lab Clin Med 85 (1975) 337-350
23. Abe K., Aoki M., Ikeda M., et al. Clinical characteristics of familial amyotrophic lateral sclerosis with Cu/Zn superoxide dismutase gene mutations. J Neurol Sci 136 (1996) 108-116
24. Ripps M.E., Huntley G.W., Hof P.R., et al. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 92 (1995) 689-693
25. Wong P.C., Pardo C.A., Borchelt D.R., et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14 (1995) 1105-1116